Study of NGM282 in Subjects With Functional Constipation and Healthy Individuals

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Functional Constipation

In brief

The purpose of this study is to determine the effect of NGM282 on colonic transit, bile acid homeostasis, and fecal fat in subjects with functional constipation and healthy individuals.

Key facts

Study ID

NCT02649062

Run by

NGM Biopharmaceuticals, Inc

People needed

31

Starts

2015-12-01

Expected to finish

2017-01-01

Last updated by the study team

2018-03-30

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Functional constipation confirmed by modified Rome III criteria or Healthy Volunteer

You may not qualify if…

• Structural or metabolic diseases/conditions that affect the GI system
• Diagnosis of dyspepsia, IBS, or significant gastrointestinal symptoms

Where it is running

• NGM Clinical Study Site 1 — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.